Ku Reviews Exciting ESMO Data in Gastric/GEJ Cancer

Season 6 Episode 9  ·  Nov 15, 2021, 08:09 PM

Headliner
Share
Subscribe

Dr. Ku underscores key takeaways from the CheckMate649 and DESTINY-Gastric02 trials in gastric/GEJ cancer and highlights ongoing research that has the potential to further inform treatment selection and sequencing in the field

Share
Subscribe
Next
Kalyan and Mouli Provide Perspective on the Power of Personalized Medicine in HCC
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air